Hôpital Saint-Louis is a hospital in Paris, France. It was built in 1611 by architect Claude Vellefaux at the request of Henry IV of France.

During the past decade, Hematology Dpt, Hopital Saint Louis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Dpt, Hopital Saint Louis" #1 collaborator was "Celgene" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hematology Dpt, Hopital Saint Louis" are "Myelodysplastic Syndromes" (2 trials). Many other conditions were trialed in "Hematology Dpt, Hopital Saint Louis" in a lesser frequency.

Most popular intervention types in "Hematology Dpt, Hopital Saint Louis" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin beta" (1 trials), "Lenalidomide" (1 trials) and "VORINOSTAT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematology Dpt, Hopital Saint Louis" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hematology Dpt, Hopital Saint Louis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hematology Dpt, Hopital Saint Louis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hematology Dpt, Hopital Saint Louis, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".